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Repeat physical stress echocardiography in asymptomatic severe aortic stenosis 
Physical stress echocardiography in aortic stenosis 
 
Elena Ferrer-Sistach, Josep Lupón, Silvia Serrano-García, Albert Teis-Soley, Francisco 
Gual-Capllonch, Gladys Juncà-Puig, Nuria Vallejo-Camazón, Jorge López-Ayerbe, 
Antoni Bayés-Genís 
Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain; and 
CIBERCV, Instituto Carlos III, Madrid, Spain 
 
Address for correspondence: Antoni Bayes-Genis, MD, PhD, FESC, Head, Heart 
Institute. Hospital Universitari Germans Trias i Pujol, Carretera de Canyet s/n 08916. 
Badalona (Barcelona), Spain, e-mail: abayesgenis@gmail.com 
 
In severe aortic stenosis (SAS), the presence of symptoms is associated with 
ominous prognosis with 5-year mortality of 15–50% [1], and is a well-established 
indication for valve replacement [2]. On the other hand, in asymptomatic SAS, case 
management requires clinical skills, and the timing of valve replacement is unclear. 
Holistic assessment of the clinical situation (including co-morbidities and frailty), risk 
stratification, and complementary tests are critical for managing asymptomatic SAS and 
determining optimal valve replacement timing. 
In clinical practice, at the time of SAS diagnosis, approximately 50% of patients 
report being asymptomatic in their day-to-day life [1]. However, this may be due to an 
unconscious adaptive process causing them to limit the intensity of their physical 
activity. Thus, it can be difficult to determine whether a patient truly lacks symptoms, 
especially in elderly patients. Stress testing is useful for exposing symptoms, and is a 
safe technique for use in stable patients [3]; clinical practice guidelines recommend the 
use of stress testing when assessing asymptomatic SAS patients [2]. Valve replacement 
is indicated in patients who exhibit clinical signs during stress testing, or lower blood 
pressure during physical activity. However, it remains unclear whether it is of value to 
repeat a stress test to uncover symptoms in asymptomatic SAS.  
The incidence of a positive stress test in SAS ranges from 15% to 65% [3]. 
Despite this variability, stress testing exhibits good negative predictive value for 
cardiovascular events [4]. Performing echocardiographic assessment before and after 
the stress test (physical stress echocardiography, PE) provides additional physiological 
parameters that can help establish the cause of symptoms [5].  
From June 2014 to August 2019,  the value of PE and repeat PE during follow-
up in 85 asymptomatic SAS patients who were prospectively enrolled in a specialized 
valve clinic (Table 1) was investigated. Baseline PE was the key indicator for aortic 
valve replacement in 23 (27%) patients: 8 (9.4%) had dyspnea, 2 (2.4%) angina, and 16 
(18.8%) abnormal blood pressure response. Furthermore, 17 (20%) exhibited electric 
changes suggestive of ischemia, PE revealed a median gradient increase of > 20 mmHg 
during stress in 31 (36.9%) patients, ventricular dysfunction in 2 (2.4%) patients, and 
segmental disorders in 8 (9.5%) patients. Of the alterations observed during PE, those 
which were the reason to indicate valve replacement were only symptoms and abnormal 
blood pressure response. The rest of the information obtained helped to make the 
decision but it was not the main reason. 
 A second PE was performed in 27 patients (median time 16 months after the first 
PE), and a third PE was completed in 5 patients (median time 16 months after the 
second PE). The second PE was the key indication for aortic valve replacement in 9 
(33.3%) patients; it was clinically positive by symptoms in 6 (22.2%) patients: 3 (12%) 
patients had dyspnea, and 4 (14.8%) angina and abnormal blood pressure response was 
found in 4 (14.8%) patients. Electric changes occurred in 9 (33.3%) patients, and a 
median gradient increase of > 20 mmHg in 15 (55.5%) patients. Finally the third PE 
was the key indicator for aortic valve replacement in 2 (40%) patients, because itwas 
clinically positive by the symptoms. 
Present findings indicated that repeating PE during follow-up was useful for 
asymptomatic SAS management. Indeed, the key indication for valve replacement 
increased from 27% of cases at baseline PE to 33% in the second PE, and 40% in the 
third PE. This pilot study in patients with asymptomatic SAS demonstrated that PE at 
both the first visit and during follow-up was useful in  indicating valve replacement. 
Further studies in larger cohorts are needed to confirm these findings, and to establish 
the optimal time-frames for serial PE in such patients.  
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Table 1. Data of asymptomatic severe aortic stenosis patients undergoing physical 
stress echocardiography. 
Demographic data 
Women 32 (37.6) 
Age [years] 74.1 ± 9.4 
Smokers  9 (10.6) 
High blood pressure  70 (82.3) 
Diabetes mellitus 30 (35.3) 
Dyslipidemia 65 (76.4) 
Echocardiographic data 
Bicuspid aortic valve 22 (25.9) 
Peak aortic velocity [m/s] 4.3 ± 0.3 
Maximum aortic gradient [mmHg] 74.5 ± 11.1 
Mean aortic gradient [mmHg] 47 ± 8 
Aortic valve area [cm2] 0.77 ± 0.12 
LVEF [%] 67.9 ± 0.12 
Blood count 
NT-proBNP [ng/L] 294.0 (148–661) 
Data presented as number (%), mean ± standard deviation, or median and percentiles of 
25–75 (Q1–Q3). LVEF — left ventricular ejection fraction; NT-proBNP — N-terminal 
pro-B-type natriuretic peptide 
 
 
